Medical - Health Information and Search Services

Breast Cancer

Treatment is updated with the most recent articles listed on top.
To view only the last month's articles for the other sub-topics, go to our Monthly Online Newsletters page

REVIEW our Selected Breast Cancer Articles in 2008. Stay informed and updated!

Order a Search Report

If you have any questions regarding our Search Reports, please contact us at info@infomedsearch.com.

InfoMedSearch

Lifestyle Changes

An Ounce of Prevention ...

Read our selected articles and reduce your chances of Breast Cancer.

InfoMedSearch

Online Alerts

Save Time. Stay updated weekly/monthly.

Stay updated Weekly by viewing our Free InfoMedSearch Weekly Featured Articles section. Sign up for our Monthly Alerts Newsletter and have access to our Weekly Featured Articles also (link available in each Alert notification).

Breast Cancer

NIH - Medical Encyclopedia Breast cancer "There are several different types of breast cancer. Ductal carcinoma begins in the cells lining the ducts that bring milk to the nipple and accounts for more than 75% of breast cancers. Lobular carcinoma begins in the milk-secreting glands of the breast but is otherwise fairly similar in its behavior to ductal carcinoma. Other varieties of breast cancer can arise from the skin, fat, connective tissues, and other cells present in the breast. … Some women have what is known as HER2-positive breast cancer. HER2, short for human epidermal growth factor receptor-2, is a gene that helps control cell growth, division, and repair. When cells have too many copies of this gene, cell growth speeds up. It’s believed that HER2 plays a key role in turning healthy cells into cancerous ones. Some women with breast cancer have too much HER2, and are therefore considered HER2-positive. … Some families appear to have a genetic tendency for breast cancer. Two variant genes have been found that appear to account for this: BRCA1 and BRCA2. … The body's reduced ability to get rid of abnormal cells leads to damage that gradually accumulates. Women carrying mutated BRCA1 and/or BRCA2 genes start with pre-existing dysfunction of this system and have a "head start" in this damaging process. Hormones are important because they encourage cell growth. High levels of hormones during a woman's reproductive years, especially when they are not interrupted by the hormonal changes of pregnancy, appear to increase the chances that genetically damaged cells will grow and cause cancer."

Breast lumps: Types of lumps and what they mean "Causes Breast lump causes: Breast cancer Breast cyst Fibroadenoma Fibrocystic changes Hamartoma Injury or trauma to the breast Intraductal papilloma Lipoma Mastitis Milk cyst (galactocele) Phyllodes tumor. "

NIH – Breast Cancer “Breast cancer affects one in eight women during their lives. Breast cancer kills more women in the United States than any cancer except lung cancer. No one knows why some women get breast cancer, but there are a number of risk factors. Risks that you cannot change include • Age - the chance of getting breast cancer rises as a woman gets older • Genes - there are two genes, BRCA1 and BRCA2, that greatly increase the risk. Women who have family members with breast or ovarian cancer may wish to be tested. • Personal factors - beginning periods before age 12 or going through menopause after age 55 Other risks include being overweight, using hormone replacement therapy, taking birth control pills, drinking alcohol, not having children or having your first child after age 35 or having dense breasts. Symptoms of breast cancer may include a lump in the breast, a change in size or shape of the breast or discharge from a nipple. Breast self-exam and mammography can help find breast cancer early when it is most treatable. Treatment may consist of radiation, lumpectomy, mastectomy, chemotherapy and hormone therapy. “

NHS – Breast Cancer “Types of breast cancer: There are several different types of breast cancer, which can develop in different parts of the breast. The most common is known as ductal breast cancer, which develops in the cells that line the breast ducts. Ductal breast cancer accounts for about 80% of all cases of breast cancer. Other, less common types of breast cancer include lobular breast cancer, which develops in the cells that line the milk-producing lobules, inflammatory breast cancer, and Paget's disease of the breast. It is possible for breast cancer to spread to other parts of the body, such as the liver, bones, or lymph nodes (small glands that filter bacteria from the body). … Symptoms: The main symptom of breast cancer is usually a lump, or thickened area of tissue, in your breast. The majority of breast lumps are found by the women who have them, and it is very important that you are aware of any lumps, or changes in the appearance, feel, or shape of your breasts. This is important because the sooner a cancerous lump is detected, the better the chances are that it will be treated successfully. Changes to look out for You should see your GP if you notice any of the following: • a lump, or thickened area of tissue, in either breast, • discharge from either of your nipples (which may be streaked with blood), • a lump or swelling in either of your armpits,a change in the size, or shape, of one, or both, of your breasts, • dimpling on the skin of your breasts, • a rash on, or around, your nipple,a change in the appearance of your nipple, such as becoming sunken into your breast, or • pain in either of your breasts or armpits which is not related to your period. If you have a lump in your breast, it is important to remember that it may not be the result of breast cancer. In fact, 90% of breast lumps are benign (non-cancerous). For example, a breast lump may be caused by a harmless cyst (a small fluid-filled lump), or fibroadenoma (benign growths that are very common). You may also find that your breasts feel lumpy just before your period. However, if you notice any changes to one, or both, of your breasts, as listed above, you should always get it checked by your GP. “

NHS – Breast Cancer Expert (Video)

NHS – Breast Cancer Screening (Video)

Highlighted Articles

Primary tumor location impacts breast cancer survival. (Am J Surg. 2008) “CONCLUSIONS: Upper-outer quadrant breast cancers have a more favorable survival advantage when compared with tumors in other locations. Factors that negatively impacted survival included high-grade tumors, advanced stage, and race.”

Adulthood Lifetime Physical Activity and Breast Cancer. (Epidemiology. 2008) “Women who increased their recreational activity in their 50s had significantly reduced risk, with those in the highest tertile of change being at a 27% lower risk. CONCLUSIONS:: Leisure-time moderate-to-vigorous activities reduce breast cancer risk irrespective of underlying host characteristics.”

Cruciferous vegetables, the GSTP1 Ile105Val genetic polymorphism, and breast cancer risk. (Am J Clin Nutr. 2008) “CONCLUSIONS: Cruciferous vegetable intake consistent with high isothiocyanate exposure may reduce breast cancer risk. Cruciferous vegetable intake also may ameliorate the effects of the GSTP1 genotype.”

Breast Cancer: Benign Breast Lumps (2007) “Eighty percent of all breast lumps are benign, which means they're not cancerous. Benign breast lumps usually have smooth edges and can be moved slightly when you push against them. They are often found in both breasts.

Mammographic Breast Density as a General Marker of Breast Cancer Risk (Cancer Epidemiology Biomarkers & Prevention 2007) "Overall mammographic density seems to represent a general marker of breast cancer risk that is not specific to breast side or location of the eventual cancer."

Lifetime physical activity and the risk of breast cancer: A case-control study. (Cancer Detect Prev. 2007) "Conclusions: These data are in concordance with the hypothesis that lifetime total physical activity is associated with decreased breast cancer risk. They also suggest that recreational physical activity at ages 14-20 years is the most beneficial. In addition, these findings confirm the majority of previous reports which implicated physical inactivity as important risk factor for breast cancer."

Highlighted Internet Sites

NCI - Breast Cancer

NCI – What You Need To Know About Breast Cancer

NCI - Characteristics of Breast Cancer Cases (graphic data)

NIH – Breast Cancer

NCI - Breast Cancer (PDQ®): Prevention

Continue your InfoMedSearch research with our previous InfoMedLinks. Start with InfoMedLinks 2008.

Searching for more specific information related to your condition? InfoMedSearch researchers can search and provide you with a custom report. We can also keep you updated. Great Price! Check out our Search Services page. Use our experience to find the important medical information you need. Help protect you and your family's health.

Custom Search

Notes

View Treatment Guidelines from previous years. Go to Treatment for each year.

Breast Cancer

Daily Treatment Report

Cognitive Therapy-CBT-Psychotherapy

Device Therapy

 

Drug Side-Effects and Interactions

Tamoxifen May Up Risk of Second, More Aggressive Breast Cancer: But survivors shouldn't stop taking the anti-cancer drug, experts say

Chemotherapy-Induced Peripheral Neuropathy as a Predictor of Neuropathic Pain in Breast Cancer Patients Previously Treated with Paclitaxel (The Journal of Pain 2009)

Common Chemotherapy Drug Can Trigger Fatal Allergic Reactions “Two patients who died from an allergic reaction had early-stage breast cancer, which had been surgically removed, and were being treated with Cremophor-containing paclitaxel to prevent the cancer from coming back. Both of these patients had received medications before the chemotherapy to reduce the risk of hypersensitivity reactions.”

Incidence of bisphosphonate-associated osteonecrosis of the jaws in breast cancer patients. (Cancer. 2009)

Drugs

Mayo Clinic researchers say breast cancer survival improves Herceptin used with chemotherapy

Aromatase inhibitors for treatment of advanced breast cancer in postmenopausal women. (Cochrane Database Syst Rev. 2009) “BACKGROUND: Endocrine therapy removes the influence of oestrogen on breast cancer cells and so hormonal treatments such as tamoxifen, megestrol acetate and medroxyprogesterone acetate have been in use for many years for advanced breast cancer. Aromatase inhibitors (AIs) inhibit oestrogen synthesis in the peripheral tissues and have a similar tumour-regressing effect to other endocrine treatments. Aminoglutethimide was the first AI in clinical use and now the third generation AIs, anastrozole, exemestane and letrozole, are in current use. Randomised trial evidence on response rates and side effects of these drugs is still limited. OBJECTIVES: To compare AIs to other endocrine therapy in the treatment of advanced breast cancer in postmenopausal women. … AUTHORS' CONCLUSIONS: In women with advanced (metastatic) breast cancer, aromatase inhibitors including those in current clinical use show a survival benefit when compared to other endocrine therapy.”

Newer Drug Beats Tamoxifen for Older Breast Cancer Patients “For postmenopausal women with breast cancer, treatment with the drug letrozole (Femara) increases survival after surgery more than the widely used tamoxifen, a new study confirms. Both letrozole and tamoxifen have been used to prevent recurrence of breast cancer in postmenopausal women with hormone receptor-positive cancer, but whether one drug is better than the other has been unclear. The new study compared the impact of the newer drug, letrozole, to tamoxifen. "This study reinforces the benefits of letrozole over tamoxifen, and leaves five years upfront use [of letrozole] as the preferred option, especially in patients judged to be at higher risk for recurrence," said lead researcher Dr. Alan Coates, co-chair of the scientific committee of the International Breast Cancer Study Group and a clinical professor in the School of Public Health at the University of Sydney, Australia. The report is published in the Aug. 20 issue of the New England Journal of Medicine.”

Pharmacogenomics of Tamoxifen Therapy. (Clin Chem. 2009) “SUMMARY: Accordingly, CYP2D6 (cytochrome P450, family 2, subfamily D, polypeptide 6) genotyping before treatment to predict metabolizer status may open new avenues for individualizing endocrine treatment, with the maximum benefit being expected for extensive metabolizers. Moreover, strong CYP2D6 inhibitors such as the selective serotonin reuptake inhibitors paroxetine and fluoxetine, which are used to treat hot flashes, should be avoided because they severely impair formation of the active metabolites.”

No Survival Benefit Seen With Taxanes in Early Breast Cancer “Docetaxel (Taxotere, sanofi-aventis) added to standard anthracycline-based adjuvant chemotherapy had no overall effect on disease-free survival among patients with early breast cancer, according to results of a study published in the May 16 issue of the Lancet. These results contrast with those from other adjuvant trials, which showed a modest survival benefit when sequential docetaxel was added to the standard treatment regimen. However, the data also suggest that estrogen-receptor (ER) and human epidermal growth-factor receptor-2 (HER2) status might be able to help predict response to taxane-based therapy.”

Herceptin Proven To Benefit Women With HER2 Positive Early Breast Cancer Latest Results From The HERA Study

Exercise

Arm exercises may cut swelling in breast cancer survivors “Slowly building strength with upper-body weight-lifting can relieve some of the arm and hand swelling that occurs in breast cancer survivors who have had lymph nodes under their arms removed, U.S. researchers said on Wednesday. After a year, women who did a twice weekly workout while wearing a compression garment had less arm pain and swelling, a condition known as lymphedema. "Weight lifting reduced the number and severity of arm and hand symptoms, increased muscular strength and reduced the incidence of lymphedema," a team at the University of Pennsylvania School of Medicine reported in the New England Journal of Medicine.”

Physical Activity and Risk of Recurrence and Mortality in Breast Cancer Survivors: Findings from the LACE Study (Cancer Epidemiol Biomarkers Prev 2009)

General Information

Metabolic profile, physical activity, and mortality in breast cancer patients. (Breast Cancer Res Treat. 2009)

The role of PET CT to evaluate the response to neoadjuvant chemotherapy in advanced breast cancer: Comparison with ultrasonography and magnetic resonance imaging. (J Surg Oncol. 2009)

Breast Cancer Pain Can Last for Years

Breast Cancer Recurrence in Older Women Five to Ten Years after Diagnosis. (Cancer Epidemiol Biomarkers Prev. 2009)

Risk for Breast Cancer Recurrence Decreased by Lifestyle Changes

HER2 breast cancer therapies: a review (Biologics. 2009)

MRI May Cause More Harm Than Good In Newly Diagnosed Early Breast Cancer “A new review says using magnetic resonance imaging (MRI) before surgery to assess the extent of early breast cancer has not been shown to improve surgical planning, reduce follow-up surgery, or reduce the risk of local recurrences.”

Elderly breast cancer patients receive chemotherapy if treated in private practices

Guidelines

NGC - Early and locally advanced breast cancer. Diagnosis and treatment. (2009)

NGC - Advanced breast cancer. Diagnosis and treatment. (2009)

Breast Cancer Radiation Guidelines Called Positive Step

NGC - Fulvestrant for systemic therapy of locally advanced or metastatic breast cancer in postmenopausal women: guideline recommendations. (2008)

NCCN 2009: Guidelines for Breast Cancer Updated

NCCN Clinical Practice Guidelines in Oncology™ Breast Cancer (2009)

Immunotherapy

 

Internet Sites

Treatment Information

DrugBank (drug structure)

FDA - MedWatch (Drug Alerts)

National Comprehensive Cancer Network

NCI - Breast Cancer (PDQ®): Treatment

NCI - Dictionary of Cancer Terms

NCI - Drug Dictionary

NCI - Overview of Nutrition in Cancer Care

Drug-Food-Supplement Information

Drug Information Online

Drug Interaction Checker

DrugDigest (drug interactions)

FDA - Drug Interactions: What You Should Know

NIH - Botanical Dietary Supplements: Background Information

NIH - Drug, Supplements, and Herbal Information

NIH - Herbal Supplements: Consider Safety, Too

NIH - Medicines

NIH - Vitamin and Mineral Supplement Fact Sheets

Nutrition

Pomegranate fruit extract impairs invasion and motility in human breast cancer. (Integr Cancer Ther. 2009)

Green tea consumption and breast cancer risk or recurrence: a meta-analysis. (Breast Cancer Res Treat. 2009) “Combining all studies of breast cancer incidence resulted in significant heterogeneity. Available epidemiologic evidence supports the hypothesis that increased green tea consumption may be inversely associated with risk of breast cancer recurrence. The association between green tea consumption and breast cancer incidence remains unclear based on the current evidence.”

Soy isoflavones and risk of cancer recurrence in a cohort of breast cancer survivors: the Life After Cancer Epidemiology study. (Breast Cancer Res Treat. 2009)

Other

Radiation-Chemotherapy

Other Treatments

Experimental

Radiotherapy

Late Effects of Breast Radiotherapy in Young Women. (Breast Dis. 2009)

Post-operative radiotherapy for ductal carcinoma in situ of the breast. (Cochrane Database Syst Rev. 2009)

Chest Wall Radiotherapy: Middle Ground for Treatment of Patients with One to Three Positive Lymph Nodes After Mastectomy. (Int J Radiat Oncol Biol Phys. 2009)

Radiation benefits women with early breast cancer “A review of published studies confirms that the addition of radiation therapy to breast-conserving surgery in the treatment of a noninvasive early form of breast cancer called ductal carcinoma in situ (DCIS) substantially decreases the risk of recurrence of either DCIS or invasive breast cancer in the affected breast.”

Supplements-Vitamins-CAM

Surgery

Surgical margins in breast conservation therapy: how much should we excise? (South Med J. 2009)

What is an Adequate Margin for Breast-Conserving Surgery? Surgeon Attitudes and Correlates. (Ann Surg Oncol. 2009)

Mastectomy Rates Are Rising

Transplantation

 

go to the topGo to the top

© 2004-2010, InfoMedSearch, LLC. All rights reserved. | Site design: mqstudio